Literature DB >> 9330015

A controlled family study of late-onset non-affective psychosis (late paraphrenia).

R J Howard1, C Graham, P Sham, J Dennehey, D J Castle, R Levy, R Murray.   

Abstract

BACKGROUND: The relationship between those schizophrenia-like conditions that have their onset in late life and early-onset schizophrenia is unclear. Very few family history studies of patients with late-onset psychosis have been reported, and it is not known whether their relatives have an increased risk of psychosis.
METHOD: Information was collected on the psychiatric morbidity of 269 first-degree relatives of patients with schizophrenia or delusional disorder with an onset after the age of 60 (late paraphrenia), and 272 first-degree relatives of healthy elderly control subjects, using a research diagnostic instrument.
RESULTS: With a narrow age range (15-50 years) at risk, the estimated lifetime risk of schizophrenia was 1.3% in the relatives of both cases and controls. With a wider age range (15-90 years) at risk, estimated lifetime risk of schizophrenia was 2.3% for the relatives of cases and 2.2% for the relatives of controls. However, depression was significantly more common among the relatives of cases than controls.
CONCLUSIONS: Those schizophrenia-like psychoses with onset in late life are not genetically associated with schizophrenia.

Entities:  

Mesh:

Year:  1997        PMID: 9330015     DOI: 10.1192/bjp.170.6.511

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  6 in total

Review 1.  Late-onset schizophrenia: epidemiology, diagnosis, management and outcomes.

Authors:  P A Wynn Owen; D J Castle
Journal:  Drugs Aging       Date:  1999-08       Impact factor: 3.923

Review 2.  Antipsychotic drug treatment for elderly people with late-onset schizophrenia.

Authors:  Adib Essali; Ghassan Ali
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 3.  The epidemiology of functional psychoses of late onset.

Authors:  A S Henderson; D W Kay
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

4.  Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole.

Authors:  Izchak Kohen; Paula E Lester; Sum Lam
Journal:  Neuropsychiatr Dis Treat       Date:  2010-03-24       Impact factor: 2.570

5.  A plausible model of schizophrenia must incorporate psychological and social, as well as neuro developmental, risk factors.

Authors:  E Bramon; R M Murray
Journal:  Dialogues Clin Neurosci       Date:  2001-12       Impact factor: 5.986

6.  Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial.

Authors:  Robert Howard; Elizabeth Cort; Rosie Bradley; Emma Harper; Linda Kelly; Peter Bentham; Craig Ritchie; Suzanne Reeves; Waleed Fawzi; Gill Livingston; Andrew Sommerlad; Sabu Oomman; Ejaz Nazir; Ramin Nilforooshan; Robert Barber; Chris Fox; Ajay Verma Macharouthu; Pranathi Ramachandra; Vivek Pattan; John Sykes; Val Curran; Cornelius Katona; Tom Dening; Martin Knapp; Richard Gray
Journal:  Lancet Psychiatry       Date:  2018-06-04       Impact factor: 27.083

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.